SCHEMBL1694804

SCHEMBL1694804

N#Cc1c(N)ncnc1NCCc1nc2cccc(F)c2cc1C(=O)NCc1cccnc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.43
MAPK8 P45983 2/20 0.43
MAPK9 P45984 2/20 0.43
MAPK10 P53779 2/20 0.43
ROCK2 O75116 1/20 0.43
CSF1R P07333 1/20 0.43
CSNK1D P48730 1/20 0.43
PRKD2 Q9BZL6 1/20 0.43
ALDH1A1 P00352 6/20 0.42
LMNA P02545 3/20 0.42
PDPK1 O15530 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PIK3CD O00329 2/20 0.40
MMP13 P45452 1/20 0.40
KDM4E B2RXH2 2/20 0.38
AURKA O14965 2/20 0.38
RPS6KB1 P23443 2/20 0.38
AURKB Q96GD4 1/20 0.38
USP2 O75604 2/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695223 0.92 MAPK8 (0.43) MAPK1MAPK8MAPK9MAPK10PDPK1
SCHEMBL1695196 0.87 MAPK1 (0.43) MAPK1MAPK8MAPK9MAPK10ROCK2
SCHEMBL1695305 0.87 PIK3CD (0.47) PIK3CDCYP3A4
SCHEMBL1694838 0.87 KDM4E (0.42) ALDH1A1LMNAPDPK1SMN1; SMN2PIK3CD
SCHEMBL1695234 0.86 PIK3CD (0.41) PIK3CDRPS6KB1MEN1CYP3A4KMT2A
SCHEMBL1695017 0.86 PIK3CD (0.45) PIK3CDCYP3A4
SCHEMBL1695256 0.85 PIK3CD (0.40) PIK3CDCYP3A4
SCHEMBL1695471 0.83 PIK3CD (0.38) PIK3CDRPS6KB1CYP3A4
SCHEMBL1694800 0.83 PIK3CD (0.54) PIK3CDCYP3A4
SCHEMBL10147655 0.83 PIK3CD (0.54) PIK3CDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588467-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003274-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed